Newsletter | April 3, 2024

04.03.24 -- How Pharma 4.0 Can Unlock The Full Potential Of External Manufacturing

SPONSOR

Webinar: Optimizing Pediatric Product Development For Commercialization Success

Join us on April 10th to discover the secrets of streamlining your pediatric product development journey. We’ll cover regulatory requirements and challenges in formulation development associated with the diversity of the population. We’ll also explore various dosing solutions and strategies that can efficiently address these formulation challenges. Click here to learn more.

FEATURED EDITORIAL

How Pharma 4.0 Can Unlock The Full Potential Of External Manufacturing

To address today's challenges and other headwinds, pharma/biotech organizations and CMO/CDMO partners need to re-evaluate and improve externalized operating models. Consider further investing in digitalizing collaboration processes as part of operational excellence and digital transformation road map efforts. 

Creating T Cell Vaccines In The Sands

Like others, Saudi Arabia has been dependent on vaccine supply from abroad. That’s about to change. According to the CEO of Emergex, the Saudis intend to produce a new generation of vaccines — predominantly based on "T cell priming, the next step beyond mRNA vaccines.”

INDUSTRY INSIGHTS

Solid Form Screening Of Active Pharmaceutical Ingredients

Explore the role of solid form services in helping meet accelerated timelines of the drug development life cycle along with examples of robust workflows for fast and thorough solid form screens.

Maximizing Drug Formulations For First-In-Human Trials

Discover the importance of drug product formulation and manufacture for FIH trials, and how they can determine if the correct dosage is safely provided and, ultimately, gain regulatory approval.

Solutions For Sustainable Chemistry And Supply Chain

Examine how a CRDMO committed to delivering innovative solutions can help meet the unique needs of clients in the pharmaceutical and biotechnology industries.

Utilizing Nanoparticle Technologies For A More Sustainable Value Chain

The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

Adapting To Change – API Custom Development And Manufacturing

A pharmaceutical company sought a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company, a molecule in clinical Phase 2/3 trials.

SOLUTIONS

Nasal Spray Development And Manufacturing Services

Finding a partner with experts who are adept at working with complex, sensitive, and potent APIs; screening for the optimal formulation; and scaling up efficiently is vital for successful trials and commercialization.

Development And Manufacturing Services

Adare Pharma Solutions is a leading specialty contract development and manufacturing organization (CDMO) and a leading global provider of advanced pharmaceutical technologies, formulation, development, and manufacturing.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: